{
  "main_header": {
    "sid": 981259,
    "name": "Sampre Nutrition",
    "stock_name": "Sampre Nutrition",
    "full_name": "Sampre Nutritions Ltd",
    "name_url": "stocks-analysis/sampre-nutrition",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.44",
    "chg": -0.21,
    "chgp": "-3.72%",
    "dir": -1,
    "prev_price": "5.65",
    "mcapval": "51.68 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530617,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "India SENSEX",
    "isin": "INE375C01022",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "2.76 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sampre-nutrition-981259-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 10,
    "sid": "981259",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sampre-nutritions-981259"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Sep-2026",
      "details": "Closure of Trading Window for the Second Quarter ended 30 September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Allotment Of 1770710 Equity Shares Upon Conversion Of Unsecured Loan On A Preferential Basis",
      "datetime": "25-Sep-2026",
      "details": "Allotment of 1770710 fully paid-up equity shares having a face value of INR 5 each at an issue price of INR 42 each including a premium of INR 37 each aggregating to INR 74369820 only upon conversion of unsecured loan on a preferential basis to Brahma Gurbani and Meera Gurbani pursuant to the special resolution passed by the members of the Company on 10 December 2025 and in accordance with the In-Principle Approval granted by BSE Limited vide letter ref: LOD/PREF/KS/FIP/726/2026-27 dated 28 August 2026.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "05-Sep-2026",
      "details": "Consolidated Voting Results with the Scrutinizers Report for the 35th Annual General Meeting.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>5:10</strong> stock split, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News